We are live on ! Find out more
IMGO

Imago BioSciences, Inc. Common stock
IMGO

Delisted

IMGO was delisted on the 10th of January, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Imago BioSciences, Inc. Common stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 105 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 106 → 0 (-106)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $1.05B → $0 (-$1.05B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 105

Holders
–
Holders Change
-106
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
105
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$161M
2
FLSM
Frazier Life Sciences Management
California
-$143M
3
OFM
Omega Fund Management
Massachusetts
-$109M
4
Blackstone Inc
Blackstone Inc
New York
-$85.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$45.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
76
Walleye Capital
New York
– -$442K -12,299 Closed
Deutsche Bank
77
Deutsche Bank
Germany
– -$435K -12,094 Closed
ACM
78
Aquatic Capital Management
Illinois
– -$399K -11,100 Closed
Mirae Asset Global Investments
79
Mirae Asset Global Investments
South Korea
– -$399K -11,091 Closed
VOYA Investment Management
80
VOYA Investment Management
Georgia
– -$382K -10,617 Closed
Ameriprise
81
Ameriprise
Minnesota
– -$374K -10,409 Closed
Manulife (Manufacturers Life Insurance)
82
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$369K -10,270 Closed
JF
83
Jump Financial
Illinois
– -$343K -9,538 Closed
PCM
84
PenderFund Capital Management
British Columbia, Canada
– -$453K -9,300 Closed
Invesco
85
Invesco
Georgia
– -$302K -8,400 Closed
Principal Financial Group
86
Principal Financial Group
Iowa
– -$300K -8,356 Closed
Morgan Stanley
87
Morgan Stanley
New York
– -$267K -7,415 Closed
Legal & General Group
88
Legal & General Group
United Kingdom
– -$239K -6,638 Closed
State Board of Administration of Florida Retirement System
89
State Board of Administration of Florida Retirement System
Florida
– -$234K -6,520 Closed
ECM
90
ExodusPoint Capital Management
New York
– -$227K -6,328 Closed
SG Americas Securities
91
SG Americas Securities
New York
– -$164K -4,564 Closed
Skandinaviska Enskilda Banken (SEB)
92
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$160K -4,452 Closed
VEA
93
Virtus ETF Advisers
New York
– -$140K -3,904 Closed
AB
94
Amalgamated Bank
New York
– -$139K -3,856 Closed
TRCT
95
Tower Research Capital (TRC)
New York
– -$125K -3,493 Closed
Royal Bank of Canada
96
Royal Bank of Canada
Ontario, Canada
– -$123K -3,428 Closed
Zurich Cantonal Bank
97
Zurich Cantonal Bank
Switzerland
– -$79.6K -2,213 Closed
MLICM
98
Metropolitan Life Insurance Company (MetLife)
New York
– -$61.4K -1,707 Closed
Nisa Investment Advisors
99
Nisa Investment Advisors
Missouri
– -$31K -868 Closed
QT
100
Quantbot Technologies
New York
– -$21.6K -600 Closed
1 2 3
4
5

IMGO Hedge Fund Activity: Q1 2023 in Review

0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q1 2023, worth a combined $0 — down 100% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 105 funds closed out of IMGO and 0 opened new positions — a net loss of 105 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $161M sold.

  • 0 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q1 2023, down from 106 in Q4 2022.
  • Funds reported $0 of Imago BioSciences, Inc. Common stock stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Imago BioSciences, Inc. Common stock positions in Q1 2023 and 105 closed out, a net change of -105 holders.
  • The largest Imago BioSciences, Inc. Common stock seller in Q1 2023 was BlackRock, an estimated $161M sold.

Based on aggregated 13F filings for Q1 2023.